Mirum Pharmaceuticals (MIRM) Share-based Compensation Growth (1y) (2020 - 2026)
Mirum Pharmaceuticals (MIRM) Share-based Compensation Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-69.95% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mirum Pharmaceuticals |
6.29 Bn |
5.90 Bn |
131.08 Mn |
129.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
129.08% |
| Dec 31, 2025 |
43.58% |
| Sep 30, 2025 |
52.23% |
| Jun 30, 2025 |
56.05% |
| Mar 31, 2025 |
38.02% |
| Dec 31, 2024 |
36.33% |
| Sep 30, 2024 |
42.02% |
| Jun 30, 2024 |
41.62% |
| Mar 31, 2024 |
33.75% |
| Dec 31, 2023 |
40.95% |
| Sep 30, 2023 |
21.38% |
| Jun 30, 2023 |
25.84% |
| Mar 31, 2023 |
30.48% |
| Dec 31, 2022 |
23.94% |
| Sep 30, 2022 |
-6.84% |
| Jun 30, 2022 |
37.69% |
| Mar 31, 2022 |
24.14% |
| Dec 31, 2021 |
55.46% |
| Sep 30, 2021 |
116.31% |
| Jun 30, 2021 |
62.17% |
